Generate a tailored SOP for Dr. Steven De Jong. Improve your application with a focused, well-structured draft.
Steven de Jong is a Professor at the University of Groningen, where he specializes in understanding chemosensitivity in testicular germ cell tumors and the mechanisms of apoptosis in cancer. His research focuses on enhancing drug efficacy through the inhibition of pro-survival pathways and identifying novel druggable pathways in ovarian and cervical cancers. De Jong leads the TIPharma Team Cancer and is an active member of the American Association for Cancer Research, the European Society of Gynecological Oncology, and the European Cell Death Organization. He is committed to advancing the understanding of cancer treatment and improving patient outcomes through innovative research.
University of Groningen • Groningen, Netherlands
Leading research and teaching in the Medical faculty.
Standard Master's entry requirements for Economics, Business, Finance, Accounting, and Management departments within the Faculty of Economics and Business.